Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Valeo Pharma Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Valeo Pharma has a total shareholder equity of CA$-63.0M and total debt of CA$69.4M, which brings its debt-to-equity ratio to -110.1%. Its total assets and total liabilities are CA$32.2M and CA$95.2M respectively.

Anahtar bilgiler

-110.1%

Borç/özkaynak oranı

CA$69.38m

Borç

Faiz karşılama oranın/a
NakitCA$7.13m
Eşitlik-CA$63.03m
Toplam yükümlülüklerCA$95.23m
Toplam varlıklarCA$32.20m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: VPH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: VPH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: VPH has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: VPH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: VPH has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: VPH has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.6% each year


Sağlıklı şirketleri keşfedin